Population pharmacokinetics of pediatric lopinavir/ritonavir oral pellets in children living with HIV in Africa

By Chupradit S, Wamalwa DC, Maleche-Obimbo E, Kekitiinwa AR, Mwanga-Amumpaire J, Bukusi EA, Nyandiko WM, Mbuthia JK, Swanson A, the DNDi Clinical Team, Cressey TR, Punyawudho B, Musiime V, for the LIVING Study Team. Clinical Pharmacology and Therapeutics 2024. doi: 10.1002/cpt.3174

Summary: Antiretroviral therapy for children living with HIV under 3 years of age commonly includes lopinavir/ritonavir (LPV/r). The original liquid LPV/r formulation tastes bitter and requires refrigeration; an oral pellets LPV/r formulation has been developed to address these challenges. The authors developed a population pharmacokinetic model and assessed drug exposure to LPV/r when the pellets were administered twice daily to children living with HIV per World Health Organization weight bands. The pharmacokinetic analysis included data from 514 Kenyan and Ugandan children participating in the LIVING studies receiving LPV/r pellets (40/10 mg) and ABC/3TC (60/30 mg) dispersible tablets. They found that LPV/r pellets dosed in accordance with World Health Organization weight bands provide adequate LPV exposures in Kenyan and Ugandan children weighing 3.0 to 24.9 kg

The post Population pharmacokinetics of pediatric lopinavir/ritonavir oral pellets in children living with HIV in Africa first appeared on DNDi.

Ajude os pacientes negligenciados

Até o momento, desenvolvemos nove tratamentos para doenças negligenciadas, salvando milhões de vidas. Temos o objetivo de disponibilizar 25 novos tratamentos em nossos primeiros 25 anos. Você pode nos ajudar!

Organização internacional, sem fins lucrativos, que desenvolve tratamentos seguros, eficazes e acessíveis para os pacientes mais negligenciados.

DNDi Global

Entre em contato

DNDi pelo mundo

Apoie a DNDi

Faça uma doação!

Trabalhe conosco

Oportunidades

Exceto para imagens, filmes e marcas registradas que estão sujeitos aos Termos de Uso da DNDi, o conteúdo deste site está licenciado sob uma Licença Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License.